Patents by Inventor Anthony M. MAGLIOCCO

Anthony M. MAGLIOCCO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of distinguishing lung squamous cell carcinoma from head and neck squamous cell carcinoma
    Patent number: 11643692
    Abstract: A method of distinguishing between lung squamous cell carcinoma and head and neck squamous cell carcinoma using a 22-gene biomarker signature is presented.
    Type: Grant
    Filed: August 7, 2019
    Date of Patent: May 9, 2023
    Assignee: H. Lee Moffitt Cancer Center and Research Institute, Inc.
    Inventors: Anthony M. Magliocco, Soner Altiok, Farah K. Khalil, Yin Xiong
  • Method of distinguishing urothelial carcinoma from lung and head and neck squamous cell carcinoma
    Patent number: 11618927
    Abstract: A method of distinguishing between urothelial carcinoma and squamous cell carcinoma of head and neck and lung primaries is presented. A 19-gene signature was developed which differentiates between metastatic urothelial carcinoma and squamous cell carcinoma in a metastatic site when the primary site is either known or unknown.
    Type: Grant
    Filed: February 25, 2020
    Date of Patent: April 4, 2023
    Assignee: H. Lee Moffitt Cancer Center and Research Institute, Inc.
    Inventors: Anthony M. Magliocco, Soner Altiok, Jasreman Dhillon, Yin Xiong
  • Method for measuring MRE11 in tissues to predict cystectomy or bladder sparing surgery plus chemoradiation therapy
    Patent number: 11360094
    Abstract: A method of identifying cancer patients who would be responsive to bladder sparing surgery plus chemoradiation therapy or cystectomy using expression of MRE11 in a nuclear to cytoplasmic ratio is presented.
    Type: Grant
    Filed: August 7, 2019
    Date of Patent: June 14, 2022
    Assignee: H. Lee Moffitt Cancer Center and Research Institute, Inc.
    Inventor: Anthony M. Magliocco
  • METHOD OF DISTINGUISHING UROTHELIAL CARCINOMA FROM LUNG AND HEAD AND NECK SQUAMOUS CELL CARCINOMA
    Publication number: 20200190603
    Abstract: A method of distinguishing between urothelial carcinoma and squamous cell carcinoma of head and neck and lung primaries is presented. A 19-gene signature was developed which differentiates between metastatic urothelial carcinoma and squamous cell carcinoma in a metastatic site when the primary site is either known or unknown.
    Type: Application
    Filed: February 25, 2020
    Publication date: June 18, 2020
    Inventors: Anthony M. Magliocco, Soner Altiok, Jasreman Dhillon, Xiong Yin
  • Immune gene signatures in urothelial carcinoma (UC)
    Patent number: 10583183
    Abstract: This invention relates to methods for treating subjects with bladder cancer, such as urothelial carcinoma, based on mRNA expression levels of chemokines.
    Type: Grant
    Filed: April 10, 2015
    Date of Patent: March 10, 2020
    Assignee: H. Lee Moffitt Cancer Center and Research Institute, Inc.
    Inventors: Anthony M. Magliocco, James J. Mulé, Anders Erik Berglund
  • METHOD OF DISTINGUISHING LIPOSARCOMA FROM NON-LIPOSARCOMA
    Publication number: 20200063211
    Abstract: The present invention concerns materials and methods useful for distinguishing between liposarcoma and non-liposarcoma. The invention further includes methods for treating a patient having a lesion from which a sample has been analyzed. The invention also includes arrays useful for distinguishing between liposarcoma and non-liposarcoma.
    Type: Application
    Filed: February 28, 2018
    Publication date: February 27, 2020
    Inventors: ANTHONY M. MAGLIOCCO, SONER ALTIOK, EVITA HENDERSON-JACKSON, YIN XIONG
  • METHOD FOR MEASURING MRE11 IN TISSUES TO PREDICT CYSTECTOMY OR BLADDER SPARING SURGERY PLUS CHEMORADIATION THERAPY
    Publication number: 20190391153
    Abstract: A method of identifying cancer patients who would be responsive to bladder sparing surgery plus chemoradiation therapy or cystectomy using expression of MRE11 in a nuclear to cytoplasmic ratio is presented.
    Type: Application
    Filed: August 7, 2019
    Publication date: December 26, 2019
    Inventor: Anthony M. Magliocco
  • METHOD OF DISTINGUISHING LUNG SQUAMOUS CELL CARCINOMA FROM HEAD AND NECK SQUAMOUS CELL CARCINOMA
    Publication number: 20190360028
    Abstract: A method of distinguishing between lung squamous cell carcinoma and head and neck squamous cell carcinoma using a 22-gene biomarker signature is presented.
    Type: Application
    Filed: August 7, 2019
    Publication date: November 28, 2019
    Inventors: Anthony M. Magliocco, Soner Altiok, Farah K. Khalil, Yin Xiong
  • Immune Gene Signatures in Urothelial Carcinoma (UC)
    Publication number: 20170175199
    Abstract: This invention relates to methods for selecting a treatment, treating, and predicting survival time in subjects with cancer, such as colorectal cancer, based on tumor expression levels of chemokines, cytotoxic genes, and/or dendritic cell genes.
    Type: Application
    Filed: April 10, 2015
    Publication date: June 22, 2017
    Inventors: Anthony M. MAGLIOCCO, James J. MULE, Anders Erik BERGLUND